Nonpartisan civic infrastructure
AllCiv·Legis1
·

38 U.S.C. § 1117

U.S. CodeFederalPositive Law
Compensation for disabilities occurring in Persian Gulf War veterans
About This Law
/us/usc/t38/s1117
Title
38 — Veterans’ Benefits
Chapter
PTII/CH11
Release
119-84
Release Date
2026-04-17

Section Text

Highlight any text to annotate
(a)(1) The Secretary may pay compensation under this subchapter to a Persian Gulf veteran with a qualifying chronic disability that became manifest to any degree at any time. (2) For purposes of this subsection, the term “qualifying chronic disability” means a chronic disability resulting from any of the following (or any combination of any of the following):(A) An undiagnosed illness. (B) A medically unexplained chronic multisymptom illness (such as chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome) that is defined by a cluster of signs or symptoms. (C) Any diagnosed illness that the Secretary determines in regulations prescribed under subsection (c) warrants a presumption of service-connection. (b)(1) Whenever the Secretary determines under section 1118(c) 11 See References in Text note below. of this title that a presumption of service connection previously established under this section is no longer warranted—(A) a veteran who was awarded compensation under this section on the basis of the presumption shall continue to be entitled to receive compensation under this section on that basis; and (B) a survivor of a veteran who was awarded dependency and indemnity compensation for the death of a veteran resulting from the disease on the basis of the presumption before that date shall continue to be entitled to receive dependency and indemnity compensation on that basis. (2) This subsection shall cease to be effective on September 30, 2011. (c)(1) The Secretary shall prescribe regulations to carry out this section. (2) Those regulations shall include the following:(A) A description of the period and geographical area or areas of military service in connection with which compensation under this section may be paid. (B) A description of the illnesses for which compensation under this section may be paid. (C) A description of any relevant medical characteristic (such as a latency period) associated with each such illness. (d) If a Persian Gulf veteran at a medical facility of the Department presents with any one symptom associated with Gulf War Illness, the Secretary shall ensure that health care personnel of the Department use a disability benefits questionnaire, or successor questionnaire, designed to identify Gulf War Illness, in addition to any other diagnostic actions the personnel determine appropriate. (e) A disability for which compensation under this subchapter is payable shall be considered to be service connected for purposes of all other laws of the United States. (f) For purposes of this section, the term “Persian Gulf veteran” means a veteran who served on active duty in the Armed Forces in the Southwest Asia theater of operations, Afghanistan, Israel, Egypt, Turkey, Syria, or Jordan, during the Persian Gulf War. (g) For purposes of this section, signs or symptoms that may be a manifestation of an undiagnosed illness or a chronic multisymptom illness include the following:(1) Fatigue. (2) Unexplained rashes or other dermatological signs or symptoms. (3) Headache. (4) Muscle pain. (5) Joint pain. (6) Neurological signs and symptoms. (7) Neuropsychological signs or symptoms. (8) Signs or symptoms involving the upper or lower respiratory system. (9) Sleep disturbances. (10) Gastrointestinal signs or symptoms. (11) Cardiovascular signs or symptoms. (12) Abnormal weight loss. (13) Menstrual disorders. (h)(1) If the Secretary determines with respect to a medical research project sponsored by the Department that it is necessary for the conduct of the project that Persian Gulf veterans in receipt of compensation under this section or section 1118 of this title participate in the project without the possibility of loss of service connection under either such section, the Secretary shall provide that service connection granted under either such section for disability of a veteran who participated in the research project may not be terminated. Except as provided in paragraph (2), notwithstanding any other provision of law any grant of service-connection protected under this subsection shall remain service-connected for purposes of all provisions of law under this title. (2) Paragraph (1) does not apply in a case in which—(A) the original award of compensation or service connection was based on fraud; or (B) it is clearly shown from military records that the person concerned did not have the requisite service or character of discharge. (3) The Secretary shall publish in the Federal Register a list of medical research projects sponsored by the Department for which service connection granted under this section or section 1118 of this title may not be terminated pursuant to paragraph (1). (i)(1) The Secretary shall take such actions as may be necessary to ensure that health care personnel of the Department are appropriately trained to effectively carry out this section. (2) Not less frequently than once each year, the Secretary shall submit to Congress a report on the actions taken by the Secretary to carry out paragraph (1). (Added Pub. L. 103–446, title I, § 106(a)(1), Nov. 2, 1994, 108 Stat. 4650; amended Pub. L. 105–277, div. C, title XVI, § 1602(c), Oct. 21, 1998, 112 Stat. 2681–744; Pub. L. 107–103, title II, §§ 202(a), (b)(1), (d)(1), 203(a), Dec. 27, 2001, 115 Stat. 988, 989; Pub. L. 109–233, title V, § 503(1), June 15, 2006, 120 Stat. 415; Pub. L. 117–168, title IV, § 405, Aug. 10, 2022, 136 Stat. 1783.) Editorial Notes References in TextSection 1118(c) of this title, referred to in subsec. (b)(1), was repealed by Pub. L. 117–168, title II, § 202(d)(3)(A), Aug. 10, 2022, 136 Stat. 1775. Amendments2022—Subsec. (a)(1). Pub. L. 117–168, § 405(a), substituted “became manifest to any degree at any time.” for “became manifest— “(A) during service on active duty in the Armed Forces in the Southwest Asia theater of operations during the Persian Gulf War; or “(B) to a degree of 10 percent or more during the presumptive period prescribed under subsection (b).” Subsec. (a)(2)(C). Pub. L. 117–168, § 405(b)(3), substituted “under subsection (c)” for “under subsection (d)”. Subsecs. (b), (c). Pub. L. 117–168, § 405(b)(1), (2), redesignated subsecs. (c) and (d) as (b) and (c), respectively, and struck out former subsec. (b) which read as follows: “The Secretary shall prescribe by regulation the period of time following service in the Southwest Asia theater of operations during the Persian Gulf War that the Secretary determines is appropriate for presumption of service connection for purposes of this section. The Secretary’s determination of such period of time shall be made following a review of any available credible medical or scientific evidence and the historical treatment afforded disabilities for which manifestation periods have been established and shall take into account other pertinent circumstances regarding the experiences of veterans of the Persian Gulf War.” Subsec. (d). Pub. L. 117–168, § 405(b)(2), (c), added subsec. (d) and redesignated former subsec. (d) as (c). Subsec. (f). Pub. L. 117–168, § 405(d), inserted “, Afghanistan, Israel, Egypt, Turkey, Syria, or Jordan,” after “operations”. Subsec. (i). Pub. L. 117–168, § 405(e), added subsec. (i). 2006—Subsec. (h)(1). Pub. L. 109–233 substituted “notwithstanding” for “nothwithstanding”. 2001—Subsec. (a). Pub. L. 107–103, § 202(a)(1), amended subsec. (a) generally. Prior to amendment, subsec. (a) read as follows: “The Secretary may pay compensation under this subchapter to any Persian Gulf veteran suffering from a chronic disability resulting from an undiagnosed illness (or combination of undiagnosed illnesses) that— “(1) became manifest during service on active duty in the Armed Forces in the Southwest Asia theater of operations during the Persian Gulf War; or “(2) became manifest to a degree of 10 percent or more within the presumptive period prescribed under subsection (b).” Subsec. (c)(1). Pub. L. 107–103, § 202(a)(2)(A), struck out “for an undiagnosed illness (or combination of undiagnosed illnesses)” after “service connection” in introductory provisions. Subsec. (c)(1)(A). Pub. L. 107–103, § 202(a)(2)(B), struck out “for such illness (or combination of illnesses)” after “awarded compensation under this section”. Subsec. (c)(2). Pub. L. 107–103, § 202(d)(1), substituted “on September 30, 2011” for “10 years after the first day of the fiscal year in which the National Academy of Sciences submits to the Secretary the first report under section 1603 of the Persian Gulf War Veterans Act of 1998”. Subsec. (g). Pub. L. 107–103, § 202(b)(1), added subsec. (g). Subsec. (h). Pub. L. 107–103, § 203(a), added subsec. (h). 1998—Subsecs. (c) to (f). Pub. L. 105–277 added subsec. (c) and redesignated former subsecs. (c) to (e) as (d) to (f), respectively. Statutory Notes and Related Subsidiaries Effective Date of 2001 AmendmentPub. L. 107–103, title II, § 202(c), Dec. 27, 2001, 115 Stat. 989, provided that: “The amendments made by subsections (a) and (b) [amending this section and section 1118 of this title] shall take effect on March 1, 2002.” Pub. L. 107–103, title II, § 203(b), Dec. 27, 2001, 115 Stat. 990, provided that: “The authority provided by subsection (h) of section 1117 of title 38, United States Code, as added by subsection (a), may be used by the Secretary of Veterans Affairs with respect to any medical research project of the Department of Veterans Affairs, whether commenced before, on, or after the date of the enactment of this Act [Dec. 27, 2001].” RegulationsPub. L. 103–446, title I, § 106(d), Nov. 2, 1994, 108 Stat. 4651, provided that: “If the Secretary states in the report under subsection (c) [set out below] that the Secretary intends to pay compensation as provided in section 1117 of title 38, United States Code, as added by subsection (a), the Secretary shall, not later than 30 days after the date on which such report is submitted, publish in the Federal Register proposed regulations under subsections (b) and (c) of that section.” Agreement With National Academy of Sciences Regarding Evaluation of Health Consequences of Service in Southwest Asia During the Persian Gulf WarPub. L. 105–368, title I, § 101, Nov. 11, 1998, 112 Stat. 3317, as amended by Pub. L. 111–275, title VIII, § 806(b)(1), (2), Oct. 13, 2010, 124 Stat. 2891, provided that the Secretary of Veterans Affairs was to enter into an agreement with the National Academy of Sciences to review and evaluate the available scientific evidence regarding associations between illness and service in the Southwest Asia theater of operations during the Persian Gulf War, and that the section would cease to be effective on Oct. 1, 2018. Improving Effectiveness of Care of Persian Gulf War VeteransPub. L. 105–368, title I, § 105, Nov. 11, 1998, 112 Stat. 3324, provided that: “(a) Assessment by National Academy of Sciences.—Not later than April 1, 1999, the Secretary of Veterans Affairs shall enter into a contract with the National Academy of Sciences to review the available scientific data in order to—“(1) assess whether a methodology could be used by the Department of Veterans Affairs for determining the efficacy of treatments furnished to, and health outcomes (including functional status) of, Persian Gulf War veterans who have been treated for illnesses which may be associated with their service in the Persian Gulf War; and “(2) identify, to the extent feasible, with respect to each undiagnosed illness prevalent among such veterans and for any other chronic illness that the Academy determines to warrant such review, empirically valid models of treatment for such illness which employ successful treatment modalities for populations with similar symptoms. “(b) Action on Report.—(1) After receiving the final report of the National Academy of Sciences under subsection (a), the Secretary shall, if a reasonable and scientifically feasible methodology is identified by the Academy, develop an appropriate mechanism to monitor and study the effectiveness of treatments furnished to, and health outcomes of, Persian Gulf War veterans who suffer from diagnosed and undiagnosed illnesses which may be associated with their service in the Persian Gulf War. “(2) The Secretary shall submit to the Committees on Veterans’ Affairs of the Senate and House of Representatives a report on the implementation of paragraph (1). “(3) The Secretary shall carry out paragraphs (1) and (2) not later than 180 days after receiving the final report of the National Academy of Sciences under subsection (a).” Agreement With National Academy of Sciences Regarding Toxic Drugs and Illnesses Associated With Gulf WarPub. L. 105–277, div. C, title XVI, §§ 1603–1605, Oct. 21, 1998, 112 Stat. 2681–745 to 2681–748, as amended by Pub. L. 107–103, title II, § 202(d)(2), Dec. 27, 2001, 115 Stat. 989; Pub. L. 111–275, title VIII, § 806(a), (b)(3), Oct. 13, 2010, 124 Stat. 2890, 2893, provided that: Persian Gulf War Veterans’ BenefitsPub. L. 103–446, title I, §§ 102–105, 107, 109, 110, Nov. 2, 1994, 108 Stat. 4647–4650, 4652–4654, as amended by Pub. L. 104–262, title III, § 352(a), Oct. 9, 1996, 110 Stat. 3210; Pub. L. 105–368, title I, § 107, Nov. 11, 1998, 112 Stat. 3325; Pub. L. 106–117, title II, § 205(b), (c), Nov. 30, 1999, 113 Stat. 1563; Pub. L. 115–182, title I, § 144(a)(3), June 6, 2018, 132 Stat. 1430, provided that: [Pub. L. 104–262, title III, § 352(b), Oct. 9, 1996, 110 Stat. 3211, provided that: “Any diagnostic testing and medical examinations undertaken by the Secretary of Veterans Affairs for the purpose of the study required by subsection (a) of such section [section 107(a) of Pub. L. 103–446, set out above] during the period beginning on October 1, 1996, and ending on the date of the enactment of this Act [Oct. 9, 1996] is hereby ratified.” ] Report to Congress on Intention To Pay CompensationSection 106(c) of Pub. L. 103–446 directed Secretary of Veterans Affairs, not later than 60 days after Nov. 2, 1994, to submit to Congress a report stating whether or not the Secretary intended to pay compensation as provided in this section. Executive Documents Executive Order No. 12961 Ex. Ord. No. 12961, May 26, 1995, 60 F.R. 28507, which established the Presidential Advisory Committee on Gulf War Veterans’ Illnesses, was revoked by Ex. Ord. No. 13138, § 3(g), Sept. 30, 1999, 64 F.R. 53880, formerly set out as a note under section 1013 of Title 5, Government Organization and Employees. Ex. Ord. No. 13034. Extension of Presidential Advisory Committee on Gulf War Veterans’ Illnesses Ex. Ord. No. 13034, Jan. 30, 1997, 62 F.R. 5137, provided: By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows: Section 1. Extension. The Presidential Advisory Committee on Gulf War Veterans’ Illnesses (the “Committee”), established pursuant to Executive Order 12961 [formerly set out above] of May 26, 1995, is hereby extended for the purposes set forth herein. All provisions of that order relating to membership and administration shall remain in effect. All Committee appointments, as well as the President’s designation of a Chairperson, shall remain in effect. The limitations set forth in section 2(c)–(e) and section 4(a) of Executive Order 12961 shall also remain in effect. The Committee shall remain subject to the Federal Advisory Committee Act, as amended, [former] 5 U.S.C. App. [see 5 U.S.C. 1001 et seq.]. Sec. 2. Functions. (a) The Committee shall report to the President through the Secretary of Defense, the Secretary of Veterans Affairs, and the Secretary of Health and Human Services. (b) The Committee shall have two principal roles: (1) Oversight of the ongoing investigation being conducted by the Department of Defense with the assistance, as appropriate, of other executive departments and agencies into possible chemical or biological warfare agent exposures during the Gulf War; and (2) Evaluation of the Federal Government’s plan for and progress towards the implementation of the Committee’s recommendations contained in its Final Report submitted on December 31, 1996. (c) The Committee shall provide advice and recommendations related to its oversight and evaluation responsibilities. (d) The Committee may also provide additional advice and recommendations prompted by any new developments related to its original functions as set forth in section 2(b) of Executive Order 12961. (e) The Committee shall submit by letter a status report by April 30, 1997, and a final supplemental report by October 31, 1997, unless otherwise directed by the President. Sec. 3. General Provisions. (a) The Committee shall terminate 30 days after submitting its final supplemental report. (b) This order is intended only to improve the internal management of the executive branch and it is not intended to create any right, benefit or trust responsibility, substantive or procedural, enforceable at law or equity by a party against the United States, its agencies, its officers, or any person. William J. Clinton.

Take Action

Your position
Add a comment
to comment on this section.
Annotate the text
Highlight any passage on the Full Text tab to attach a note. Annotations appear on the Annotations tab.